Further Development and Validation of the frog Embryo Teratogenesis Assay - Xenopus (FETAX)

reportActive / Technical Report | Accession Number: ADA236986 | Open PDF

Abstract:

The goal of the project was to develop and validate the Frog Embryo Teratogenesis Assay- Xenopus FETAX. FETAX is a 96 h whole embryo bioassay designed to rapidly assess the developmental toxicity of pure compounds and complex mixtures. The five specific objectives of this study are 1 validate FETAX using direct-acting compounds of known mammalian developmental toxicity, 2 develop and validate an in vitro metabolic activation system using rat liver microsomes, 3 explore and use three carrier solvents which will help solubilize non-polar compounds, 4 develop an Atlas of Abnormalities as a companion manual to the ASTM New Standard Guide for the Conduct of FETAX and, 5 compare the sensitivity of FETAX with a fathead minnow bioassay modified to have the same exposure conditions as FETAX.

Security Markings

DOCUMENT & CONTEXTUAL SUMMARY

Distribution:
Approved For Public Release
Distribution Statement:
Approved For Public Release; Distribution Is Unlimited.

RECORD

Collection: TR
Identifying Numbers
Subject Terms